Revolution Medicines, Inc. (RVMD) Operating income 2018–2025
Revolution Medicines, Inc. (RVMD) annual operating income history from SEC filings — each fiscal year as reported.
-$1.2BFY2025 · since FY2018: -$40.3M → -$1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.2B | -71.5% |
| FY2024 | -$689.5M | -41.5% |
| FY2023 | -$487.2M | -88.6% |
| FY2022 | -$258.3M | -37.4% |
| FY2021 | -$188.0M | -69.8% |
| FY2020 | -$110.7M | -104.5% |
| FY2019 | -$54.1M | -34.2% |
| FY2018 | -$40.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMD financial trends
RVMD RevenueRVMD Net incomeRVMD Net marginRVMD Gross profitRVMD Gross marginRVMD Operating marginRVMD Operating cash flowRVMD Free cash flowRVMD Capital expendituresRVMD Return on equityRVMD Stock buybacksRVMD Dividends paidRVMD Total assetsRVMD Total liabilitiesRVMD Shareholders’ equityRVMD overview →